Literature DB >> 17241376

The response of the hepatocyte to ischemia.

M Massip-Salcedo1, J Roselló-Catafau, J Prieto, M A Avíla, C Peralta.   

Abstract

BACKGROUND: Ischemia-reperfusion (I/R) injury associated with hepatic resections and liver transplantation remains a serious complication in clinical practice, in spite of several attempts to solve the problem. AIMS: To evaluate the response of the hepatocyte to ischemia
METHODS: Published data are thus revised.
RESULTS: The response of the hepatocyte to ischemia is based on the sensitivity of hepatocytes to different types of ischemia, the kind of cell death of the hepatocyte when it is subjected to ischemia, and on the response of the hepatocyte to the different times and extents of ischemia. Clinical factors including starvation, graft, age, and hepatic steatosis, all of which contribute to enhancing liver susceptibility to ischemia/reperfusion injury.
CONCLUSION: Ischemic preconditioning, based on the induction of a brief ischemia to the liver prior to a prolonged ischemia, has been applied in tumor hepatic resections for reducing hepatic I/R injury and recent clinical studies suggest that this surgical strategy could be appropriate for liver transplantation.

Entities:  

Mesh:

Year:  2007        PMID: 17241376     DOI: 10.1111/j.1478-3231.2006.01390.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  29 in total

1.  Intermittent ischaemia maintains function after ischaemia reperfusion in steatotic livers.

Authors:  Mathilde Steenks; Mark C P M van Baal; Vincent B Nieuwenhuijs; Menno T de Bruijn; Marc Schiesser; Mike H Teo; Tom Callahan; Rob T A Padbury; Greg J Barritt
Journal:  HPB (Oxford)       Date:  2010-05       Impact factor: 3.647

Review 2.  Role of nitric oxide in hepatic ischemia-reperfusion injury.

Authors:  Arunotai Siriussawakul; Ahmed Zaky; John D Lang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 3.  Redox therapeutics in hepatic ischemia reperfusion injury.

Authors:  Rakesh P Patel; John D Lang; Alvin B Smith; Jack H Crawford
Journal:  World J Hepatol       Date:  2014-01-27

4.  Ischemic Hepatitis - Intercorrelated Pathology.

Authors:  Andrea Olivia Ciobanu; Leonida Gherasim
Journal:  Maedica (Bucur)       Date:  2018-03

Review 5.  Hypoxic hepatitis - epidemiology, pathophysiology and clinical management.

Authors:  Valentin Fuhrmann; Bernhard Jäger; Anna Zubkova; Andreas Drolz
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

6.  Endogenous leptin fluctuates in hepatic ischemia/reperfusion injury and represents a potential therapeutic target.

Authors:  Ji Lin; Xiao-Ning Gao; Guang-Tao Yan; Hui Xue; Xiu-Hua Hao; Lu-Huan Wang
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

7.  Exogenous Gene Transmission of Isocitrate Dehydrogenase 2 Mimics Ischemic Preconditioning Protection.

Authors:  Alexander L Kolb; Peter R Corridon; Shijun Zhang; Weimin Xu; Frank A Witzmann; Jason A Collett; George J Rhodes; Seth Winfree; Devin Bready; Zechariah J Pfeffenberger; Jeremy M Pomerantz; Takashi Hato; Glenn T Nagami; Bruce A Molitoris; David P Basile; Simon J Atkinson; Robert L Bacallao
Journal:  J Am Soc Nephrol       Date:  2018-01-25       Impact factor: 10.121

8.  Donation after cardio-circulatory death liver transplantation.

Authors:  Hieu Le Dinh; Arnaud de Roover; Abdour Kaba; Séverine Lauwick; Jean Joris; Jean Delwaide; Pierre Honoré; Michel Meurisse; Olivier Detry
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

Review 9.  Factors in the pathophysiology of the liver ischemia-reperfusion injury.

Authors:  Eduardo E Montalvo-Jave; Tomas Escalante-Tattersfield; Jose A Ortega-Salgado; Enrique Piña; David A Geller
Journal:  J Surg Res       Date:  2007-07-27       Impact factor: 2.192

10.  Suppressor of cytokine signaling expression with increasing severity of murine hepatic ischemia-reperfusion injury.

Authors:  Lorrie A Langdale; Vicki Hoagland; Whitney Benz; Kimberly J Riehle; Jean S Campbell; Denny H Liggitt; Nelson Fausto
Journal:  J Hepatol       Date:  2008-05-08       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.